Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2014 09:00 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Chairman and CEO Jeff Yordon Inducted Into the UIC Chicago Area Entrepreneurship Hall of Fame

SCHAUMBURG, Ill., Nov. 7, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) ("Sagent"), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today...
November 04, 2014 07:00 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Reports Third Quarter 2014 Financial Results

SCHAUMBURG, Ill., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
October 24, 2014 16:00 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Sets Date and Time for Release of Third Quarter 2014 Financial Results

SCHAUMBURG, Ill., Oct. 24, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced...
October 03, 2014 12:01 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Three Lots of Ketorolac Tromethamine Injection, USP, 30mg/mL Due to Labeling the Product With the Incorrect Expiration Date

SCHAUMBURG, Ill., Oct. 3, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the voluntary nationwide recall of three lots of Ketorolac Tromethamine Injection, USP,...
October 01, 2014 16:10 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces Acquisition of Omega Laboratories

Expands Sagent's Global Footprint, Product Portfolio and Industry Leading Development Pipeline Expected to be Immediately Accretive to Cash Earnings SCHAUMBURG, Ill., Oct. 1, 2014 (GLOBE...
September 26, 2014 13:41 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces the Launch of GLYDO(TM) (Lidocaine HCI Jelly USP, 2%)

SCHAUMBURG, Ill., Sept. 26, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq: SGNT) today announced the launch of GLYDO™ (lidocaine HCI jelly USP, 2%), Sagent's new branded drug...
September 23, 2014 16:05 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces the Introduction of Oxaliplatin Injection, USP

SCHAUMBURG, Ill., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the introduction of Oxaliplatin Injection, USP, an antineoplastic agent, now in two...
September 17, 2014 16:30 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces the Launch of Ketorolac Tromethamine Injection, USP

SCHAUMBURG, Ill., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Ketorolac Tromethamine Injection, USP, a nonsteroidal anti-inflammatory...
September 05, 2014 13:21 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces the Launch of Ibandronate Sodium Injection

SCHAUMBURG, Ill., Sept. 5, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Ibandronate Sodium Injection, a bisphosphonate, in a preservative-free,...
August 05, 2014 08:00 ET | Source: Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals Announces the Reintroduction of Irinotecan Hydrochloride Injection, USP

SCHAUMBURG, Ill., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the reintroduction of Irinotecan Hydrochloride Injection, USP, an antineoplastic agent, in...